Author

Kristin M. Darin

Observed names: K Darin, K. M. Darin, KM Darin, Kristin Darin, Kristin M Darin

Observed institutions: Northwestern University, Northwestern Memorial Hospital

OpenAlex ID: A5031960729

Point-of-care testing for infectious diseases: Opportunities, barriers, and considerations in community pharmacy

2014 · Paul O. Gubbins, Michael E. Klepser, et al. · Journal of the American Pharmacists Association · 103

Unintended Pregnancies Observed With Combined Use of the Levonorgestrel Contraceptive Implant and Efavirenz-based Antiretroviral Therapy: A Three-Arm Pharmacokinetic Evaluation Over 48 Weeks

2015 · Kimberly K. Scarsi, Kristin M. Darin, et al. · Clinical Infectious Diseases · 88

PDF

Pharmacist-provided rapid HIV testing in two community pharmacies

2014 · Kristin M. Darin, Michael E. Klepser, et al. · Journal of the American Pharmacists Association · 85

Adherence and Viral Suppression Among Participants of the Patient-centered Human Immunodeficiency Virus (HIV) Care Model Project: A Collaboration Between Community-based Pharmacists and HIV Clinical Providers

2019 · Kathy K Byrd, John G Hou, et al. · Clinical Infectious Diseases · 58

Atazanavir/Ritonavir-Based Combination Antiretroviral Therapy for Treatment of HIV-1 Infection in Adults

2011 · Chad J Achenbach, Kristin M Darin, et al. · Future Virology · 51

Drug–Drug Interactions, Effectiveness, and Safety of Hormonal Contraceptives in Women Living with HIV

2016 · Kimberly K. Scarsi, Kristin M. Darin, et al. · Drug Safety · 50

Efavirenz decreases etonogestrel exposure

2017 · Catherine A. Chappell, Mohammed Lamorde, et al. · AIDS · 45

Accumulation of Protease Mutations among Patients Failing Second-Line Antiretroviral Therapy and Response to Salvage Therapy in Nigeria

2013 · Holly E. Rawizza, Beth Chaplin, et al. · PLoS ONE · 40

PDF

Retention in HIV Care Among Participants in the Patient-Centered HIV Care Model: A Collaboration Between Community-Based Pharmacists and Primary Medical Providers

2019 · Kathy K. Byrd, Felicia Hardnett, et al. · AIDS Patient Care and STDs · 39

Antiretroviral Pharmacokinetics in Pregnant Women

2015 · Elise M. Gilbert, Kristin M. Darin, et al. · Pharmacotherapy The Journal of Human Pharmacology and Drug Therapy · 34

The Effect of Gene Variants on Levonorgestrel Pharmacokinetics When Combined With Antiretroviral Therapy Containing Efavirenz or Nevirapine

2017 · M Neary, M Lamorde, et al. · Clinical Pharmacology & Therapeutics · 30

Consumer interest in community pharmacy HIV screening services

2014 · Kristin M. Darin, Kimberly K. Scarsi, et al. · Journal of the American Pharmacists Association · 27

Low incidence of renal impairment observed in tenofovir-treated patients

2011 · E. P. O'Donnell, K. K. Scarsi, et al. · Journal of Antimicrobial Chemotherapy · 26

Efavirenz‐ but not nevirapine‐based antiretroviral therapy decreases exposure to the levonorgestrel released from a sub‐dermal contraceptive implant

2014 · Kimberly Scarsi, Mohammed Lamorde, et al. · Journal of the International AIDS Society · 25

Disposition of amodiaquine and desethylamodiaquine in HIV-infected Nigerian subjects on nevirapine-containing antiretroviral therapy

2014 · K. K. Scarsi, F. A. Fehintola, et al. · Journal of Antimicrobial Chemotherapy · 20

PDF

Physiologically based pharmacokinetic modelling prediction of the effects of dose adjustment in drug–drug interactions between levonorgestrel contraceptive implants and efavirenz-based ART

2017 · Owain Roberts, Rajith K R Rajoli, et al. · Journal of Antimicrobial Chemotherapy · 18

PDF

Artemether-Lumefantrine Exposure in HIV-Infected Nigerian Subjects on Nevirapine-Containing Antiretroviral Therapy

2015 · Sunil Parikh, Fatai Fehintola, et al. · Antimicrobial Agents and Chemotherapy · 15

PDF

Superior Effectiveness of Zidovudine Compared With Tenofovir When Combined With Nevirapine-based Antiretroviral Therapy in a Large Nigerian Cohort

2015 · Kimberly K. Scarsi, Geoffrey Eisen, et al. · Clinical Infectious Diseases · 14

PDF

Patterns and Predictors of First-Line Antiretroviral Therapy Modification in HIV-1-Infected Adults in a Large Urban Outpatient Cohort in Nigeria

2015 · Isaac Okoh Abah, Kristin M. Darin, et al. · Journal of the International Association of Providers of AIDS Care (JIAPAC) · 14

Clinical implications of antiretroviral drug interactions with warfarin: a case-control study

2013 · J. S. Esterly, K. M. Darin, et al. · Journal of Antimicrobial Chemotherapy · 13

PDF

Optimizing Treatment Switch for Virologic Failure during First-Line Antiretroviral Therapy in Resource-Limited Settings

2012 · Adedotun A. Adetunji, Chad Achenbach, et al. · Journal of the International Association of Providers of AIDS Care (JIAPAC) · 10

PDF

Safety and efficacy of rifabutin among HIV/TB-coinfected children on lopinavir/ritonavir-based ART

2019 · Holly E Rawizza, Kristin M Darin, et al. · Journal of Antimicrobial Chemotherapy · 9

PDF

Rifabutin pharmacokinetics and safety among TB/HIV-coinfected children receiving lopinavir/ritonavir-containing second-line ART

2020 · Holly E Rawizza, Regina Oladokun, et al. · Journal of Antimicrobial Chemotherapy · 5

A standardized health-system specialty pharmacy approach to identify and address social determinants of health

2025 · Shanece Green, Casey Fitzpatrick, et al. · American Journal of Health-System Pharmacy · 3

Efavirenz — but not nevirapine — based antiretroviral therapy significantly reduces etonogestrel concentrations among HIV-positive women using subdermal contraceptive implants

2016 · C Chappell, M Lamorde, et al. · Contraception · 1

Works count: 32

Citation count: 825

H-index: 16

I10-index: 21